Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Shortened leukocyte and placental telomeres associated with gestational diabetes mellitus (GDM) suggest this exposure triggers telomere attrition contributing to adverse outcomes. We applied high resolution Single Telomere Length Analysis (STELA) to placenta from GDM pregnancies with different treatment pathways to determine their effectiveness at preventing telomere attrition. Differences in telomere length between control (N = 69), GDM lifestyle intervention (n = 14) and GDM treated with metformin and/or insulin (n = 17) was tested by Analysis of Covariance (ANCOVA) followed by group comparisons using Fisher's least significant difference. For male placenta only, there were differences in mean telomere length (F(2,54) = 4.98, P = 0.01) and percentage of telomeres under 5 kb (F(2,54) = 4.65, P = 0.01). Telomeres were shorter in the GDM lifestyle intervention group compared to both controls (P = 0.02) and medically treated pregnancies (P = 0.003). There were more telomeres under 5 kb in the GDM lifestyle intervention group compared to the other two groups (P = 0.03 and P = 0.004). Although further work is necessary, we suggest that early adoption of targeted medical treatment of GDM pregnancies where the fetus is known to be male may be an effective strategy for ameliorating adverse outcomes for children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mothers with gestational diabetes, metformin treatment prevented telomere shortening in their male offspring (Garcia-Martin et al. 2018).”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Garcia-Martin et al. 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Diagnosis and Classification of diabetes mellitus
(2014) · Diapedia · doi:10.14496/dia..20 · Cited by 3,214
Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia.
Combs, C. A., Singh, N. B., & Khoury, J. C. (1993) · PubMed · Cited by 2,499
Switching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
A highly conserved repetitive DNA sequence,(TTAGGG) n, present at the telomeres of human chromosomes
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., & Wu, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6622 · Cited by 1,820
Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London
Sebire, N., Jolly, M., Harris, J., Wadsworth, J., Joffe, M., Beard, R., Regan, L., & Robinson, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801670 · Cited by 1,743
Maternal Obesity and Risk of Gestational Diabetes Mellitus
Chu, S. Y., Callaghan, W. M., Kim, S. Y., Schmid, C. H., Lau, J., England, L. J., & Dietz, P. M. (2007) · Diabetes Care · doi:10.2337/dc06-2559a · Cited by 1,114
Telomerase in the human organism
Collins, K., & Mitchell, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205083 · Cited by 603
Extensive allelic variation and ultrashort telomeres in senescent human cells
Baird, D. M., Rowson, J., Wynford-Thomas, D., & Kipling, D. (2003) · Nature Genetics · doi:10.1038/ng1084 · Cited by 570
Self-citationMetformin and inflammation: its potential Beyond glucose-lowering effect
Saisho, Y. (2015) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/1871530315666150316124019 · Cited by 450 · cited 1×
“A third possibility is that metformin acts indirectly by dampening down the chronic inflammations associated with GDM [37].”
The nature of telomere fusion and a definition of the critical telomere length in human cells
Capper, R., Britt-Compton, B., Tankimanova, M., Rowson, J., Letsolo, B., Man, S., Haughton, M., & Baird, D. M. (2007) · Genes & Development · doi:10.1101/gad.439107 · Cited by 294
Self-citationAnisimov, V. N., Berstein, L. M., Popovich, I. G., Zabezhinski, M. A., Egormin, P. A., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Kovalenko, I. G., et al. (2011) · Aging · doi:10.18632/aging.100273 · Cited by 285
Lifestyle interventions for the treatment of women with gestational diabetes
Brown, J., Alwan, N. A., West, J., Brown, S., McKinlay, C. J., Farrar, D., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011970.pub2 · Cited by 284
Telomeres and Telomerase: The Means to the End (Nobel Lecture)
Blackburn, E. H. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002387 · Cited by 226
Heterogeneity in White Blood Cells Has Potential to Confound DNA Methylation Measurements
Adalsteinsson, B. T., Gudnason, H., Aspelund, T., Harris, T. B., Launer, L. J., Eiriksdottir, G., Smith, A. V., & Gudnason, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046705 · Cited by 202
The fetal programming of telomere biology hypothesis: an update
Entringer, S., de Punder, K., Buss, C., & Wadhwa, P. D. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2017.0151 · Cited by 191
A longitudinal study of depression and gestational diabetes in pregnancy and the postpartum period
Hinkle, S. N., Buck Louis, G. M., Rawal, S., Zhu, Y., Albert, P. S., & Zhang, C. (2016) · Diabetologia · doi:10.1007/s00125-016-4086-1 · Cited by 185 · cited 1×
“Women diagnosed with GDM are more likely to experience pregnancy related depression [4] and seven times more likely to develop type 2 diabetes mellitus (T2DM) later in life [5].”
Gestational diabetes mellitus: Challenges for different ethnic groups
Yuen, L. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1024 · Cited by 176
Maternal outcomes and follow‐up after gestational diabetes mellitus
Kim, C. (2014) · Diabetic Medicine · doi:10.1111/dme.12382 · Cited by 149
Long-Term Health Outcomes in Offspring Born to Women with Diabetes in Pregnancy
Fraser, A., & Lawlor, D. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0489-x · Cited by 145
Simpson, R. A., Mayhew, T. M., & Barnes, P. (1992) · Placenta · doi:10.1016/0143-4004(92)90055-x · Cited by 144
Maternal Age and Prevalence of Gestational Diabetes Mellitus
Lao, T. T., Ho, L.-F., Chan, B. C. P., & Leung, W.-C. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-2568 · Cited by 138
Telomerase deficiency impairs glucose metabolism and insulin secretion
Kuhlow, D., Florian, S., von Figura, G., Weimer, S., Schulz, N., Petzke, K. J., Zarse, K., Pfeiffer, A. F. H., Rudolph, K. L., & Ristow, M. (2010) · Aging · doi:10.18632/aging.100200 · Cited by 130
Nuclear respiratory factor 1 and endurance exercise promote human telomere transcription
Diman, A., Boros, J., Poulain, F., Rodriguez, J., Purnelle, M., Episkopou, H., Bertrand, L., Francaux, M., Deldicque, L., & Decottignies, A. (2016) · Science Advances · doi:10.1126/sciadv.1600031 · Cited by 101
John, R. M., & Hemberger, M. (2012) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2012.03.018 · Cited by 93
Self-citationGirchenko, P. V., Tuovinen, S., Lahti‐Pulkkinen, M., Lahti, J. M. T., Savolainen, K., Heinonen, K., Pyhälä, R., Reynolds, R. M., Hämäläinen, E. K., Villa, P., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0061-x · Cited by 80
Reduced Fetal Telomere Length in Gestational Diabetes
Xu, J., Ye, J., Wu, Y., Zhang, H., Luo, Q., Han, C., Ye, X., Wang, H., He, J., Huang, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086161 · Cited by 70
Li, S., Zhu, Y., Yeung, E., Chavarro, J. E., Yuan, C., Field, A. E., Missmer, S. A., Mills, J. L., Hu, F. B., & Zhang, C. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx151 · Cited by 65
Holder, T., Giannini, C., Santoro, N., Pierpont, B., Shaw, M., Duran, E., Caprio, S., & Weiss, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3345-2 · Cited by 62
Gerosuppressant Metformin: less is more
Menendez, J. A., Cufí, S., Oliveras-Ferraros, C., Vellon, L., Joven, J., & Vazquez-Martin, A. (2011) · Aging · doi:10.18632/aging.100316 · Cited by 58
Jones, C. W., Gambala, C., Esteves, K. C., Wallace, M., Schlesinger, R., O’Quinn, M., Kidd, L., Theall, K. P., & Drury, S. S. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.11.1027 · Cited by 56
Moullec, N. L., Fianu, A., Maillard, O., Chazelle, É., Naty, N., Schneebeli, C., Gérardin, P., Huiart, L., Charles, M.-A. A., & Favier, F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195531 · Cited by 53
Cross, J. A., Temple, R., Hughes, J. C., Dozio, N., Brennan, C., Stanley, K., Murphy, H. R., Fowler, D., Hughes, D. A., & Sampson, M. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03099.x · Cited by 51
The influence of the telomere-telomerase system on diabetes mellitus and its vascular complications
Nan, W. Q., Ling, Z., & Bing, C. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1016500 · Cited by 47
Telomeres are shorter in placentas from pregnancies with uncontrolled diabetes
Biron‐Shental, T., Halevy, R. S., Naboani, H., Liberman, M., Kats, R., & Amiel, A. (2014) · Placenta · doi:10.1016/j.placenta.2014.11.011 · Cited by 46
The Telomeric Complex and Metabolic Disease
Kirchner, H., Shaheen, F., Kalscheuer, H., Schmid, S., Oster, H., & Lehnert, H. (2017) · Genes · doi:10.3390/genes8070176 · Cited by 44
Telomere length is reduced in 9- to 16-year-old girls exposed to gestational diabetes in utero
Hjort, L., Vryer, R., Grunnet, L. G., Burgner, D. P., Olsen, S. F., Saffery, R., & Vaag, A. A. (2018) · Diabetologia · doi:10.1007/s00125-018-4549-7 · Cited by 41
Placental expression of imprinted genes varies with sampling site and mode of delivery
Janssen, A. B., Tunster, S. J., Savory, N., Holmes, A., Beasley, J., Parveen, S., Penketh, R., & John, R. M. (2015) · Placenta · doi:10.1016/j.placenta.2015.06.011 · Cited by 34
Self-citationGiannubilo, S. R., Pasculli, A., Ballatori, C., Biagini, A., & Ciavattini, A. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.02.015 · Cited by 31
Telomere length, pre-eclampsia, and gestational diabetes
Harville, E. W., Williams, M. A., Qiu, C., Mejia, J., & Risques, R. A. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-113 · Cited by 29
Telomere length heterogeneity in placenta revealed with high-resolution telomere length analysis
García-Martín, I., Janssen, A. B., Jones, R. E., Grimstead, J. W., Penketh, R., Baird, D. M., & John, R. M. (2017) · Placenta · doi:10.1016/j.placenta.2017.09.007 · Cited by 26
Self-citationTelomere homeostasis in placentas from pregnancies with uncontrolled diabetes
Biron‐Shental, T., Liberman, M., Elbaz, M., Laish, I., Sharony, R., & Amiel, A. (2016) · Placenta · doi:10.1016/j.placenta.2016.05.009 · Cited by 13
Cited by
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
“In mothers with gestational diabetes, metformin treatment prevented telomere shortening in their male offspring (Garcia-Martin et al. 2018).”
BackgroundMetformin in aging and aging-related diseases: clinical applications and relevant mechanisms
Chen, S., Gan, D., Lin, S., Zhong, Y., Chen, M., Zou, X., Shao, Z., & Xiao, G. (2022) · Theranostics · doi:10.7150/thno.71360 · Cited by 190
Ala, M., & Ala, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00167 · Cited by 95
Metformin: A Potential Candidate for Targeting Aging Mechanisms
Hu, D., Xie, F., Xiao, Y., Chen, L., Zhong, J., Huang, D., Chen, J., Wei, J., Jiang, Y., & Zhong, T. (2021) · Aging and Disease · doi:10.14336/ad.2020.0702 · Cited by 88
Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease
Cheng, F., Liu, Y.-L., Du, J., & Lin, J. (2022) · Aging and Disease · doi:10.14336/ad.2021.1213 · Cited by 87
Metadata
- Authors
- Garcia-Martin, I., Penketh, R. J. A., Janssen, A. B., Jones, R. E., Grimstead, J., Baird, D. M., & John, R. M.
- Affiliations
- University Hospital of Wales (GB)
- Cardiff University (GB)
- Corresponding author
- John, Rosalind M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-12-11
- Volume
- 13
- Issue
- 12
- Pages
- e0208533
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6289439
- OpenAlex
- W2901584188
- Cited by
- 24
- References
- 43
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 3 · 2020: 2 · 2019: 3
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Medical Research Council (MR/M013960)
- Biotechnology and Biological Sciences Research Council (BB/F016557)
- Cancer Research UK (C17199/A18246)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, telomere shortening, metformin, insulin therapy, lifestyle intervention, fetal sex, maternal diabetes
- MeSH terms
- Adult, Analysis of Variance, Female, Humans, Hypoglycemic Agents, Insulin, Male, Metformin, Placenta, Pregnancy, Case-Control Studies, Telomere, Diabetes, Gestational, Risk Reduction Behavior, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.